Stem Cell based cure for blindness?

  • Context: Medical 
  • Thread starter Thread starter Coin
  • Start date Start date
  • Tags Tags
    Cell Stem
Click For Summary

Discussion Overview

The discussion centers on a newly developed stem cell therapy aimed at curing age-related macular degeneration (AMD), a leading cause of blindness. Participants explore the implications of this therapy, its potential availability, and the biological context of immune-privileged sites in relation to the treatment.

Discussion Character

  • Exploratory
  • Technical explanation
  • Debate/contested

Main Points Raised

  • Some participants highlight that the therapy involves replacing degenerated cells with new ones derived from embryonic stem cells, with predictions of routine availability in several years.
  • One participant expresses skepticism about the long-term implications of using embryonic stem cells, noting that recipients may need to take anti-rejection drugs from Pfizer for life.
  • Several participants discuss the concept of immune-privileged sites in the body, including the eye, and how this may relate to the therapy's effectiveness and immune response.
  • Another participant points out that while the brain has immune cells, the classification of immune-privileged sites may not fully account for the functioning of the adaptive immune system and suggests considering cartilage as another area of interest.

Areas of Agreement / Disagreement

Participants express differing views on the implications of immune-privileged sites and the nature of immune responses in these areas. There is no consensus on the characterization of immune-privileged sites or the broader implications of the stem cell therapy.

Contextual Notes

Participants reference the complexity of immune responses in immune-privileged sites and the potential need for lifelong medication, indicating a nuanced understanding of the biological context surrounding the proposed therapy.

Coin
Messages
564
Reaction score
1
From the UK's Sunday Times:

BRITISH scientists have developed the world’s first stem cell therapy to cure the most common cause of blindness. Surgeons predict it will become a routine, one-hour procedure that will be generally available in six or seven years’ time.

The treatment involves replacing a layer of degenerated cells with new ones created from embryonic stem cells. It was pioneered by scientists and surgeons from the Institute of Ophthalmology at University College London and Moorfields eye hospital.

This week Pfizer, the world’s largest pharmaceutical research company, will announce its financial backing to bring the therapy to patients.

The treatment will tackle age-related macular degeneration (AMD), the most common cause of blindness.
 
Biology news on Phys.org
I'm not surprised that Pfizer is interested in the therapy. Recipients will be required to take Pfizer's anti-rejection drugs the rest of their life if embryonic stem cells are used.
 
We have several areas of our bodies that the immune system appears to be incapable of function. These are called immune-privileged sites, and include the eye, brain, ovary and testis.
You can read more about it here.
www.mai-journal.com/interviews/streilein.pdf[/URL] -
 
Last edited by a moderator:
hypatia said:
We have several areas of our bodies that the immune system appears to be incapable of function. These are called immune-privileged sites, and include the eye, brain, ovary and testis.
You can read more about it here.
www.mai-journal.com/interviews/streilein.pdf[/URL] -[/QUOTE]Yep! Eyes appear particularly situated in the body's defense structure. If you develop Rhabdomyoscarcoma, the only approved treatment (at least when I was producing instructional materials for the ophthalmologists) was ennucleation (surgical removal of the affected eye) and the doctors would tell the patient to wrap his or her affairs up very quickly because 6 months from then, they would be dead. Never far off the mark, IMO.
 
Last edited by a moderator:
hypatia said:
We have several areas of our bodies that the immune system appears to be incapable of function. These are called immune-privileged sites, and include the eye, brain, ovary and testis.
You can read more about it here.
www.mai-journal.com/interviews/streilein.pdf[/URL] -[/QUOTE]

Interesting...although the brain does have immune cells (macrophages), so I wouldn't claim that immune-privileged sites do not have a functioning adaptive immune system. There's also the innate immune response to consider.

Cartilege would also be interesting to look at- there's no blood supply.
 
Last edited by a moderator:

Similar threads

  • · Replies 4 ·
Replies
4
Views
3K
  • · Replies 16 ·
Replies
16
Views
6K
Replies
1
Views
4K
  • · Replies 2 ·
Replies
2
Views
5K
  • · Replies 5 ·
Replies
5
Views
8K
  • · Replies 1 ·
Replies
1
Views
12K